On ECHEMI
Home > Drugs > Jilin ASEAN Pharmaceutical Co., Ltd.
Jilin ASEAN Pharmaceutical Co., Ltd.
  • Founded in:

    2013-07-22
  • Country:

    China China
  • Address:

    No. 188 Xinxing Road, Longshan District, Liaoyuan City, Jilin Province
  • Tax NO.:

    912204000722682921
  • Registered Funds:

    56.62 million yuan
  • Email:

Related Drugs
Compound acetylsalicylic acid tablets
Acetylsalicylic acid.
Name Description Content CAS NO. Registered Holders
Acetylsalicylic acid

Analgesic effect: by inhibiting the synthesis of prostaglandins and other substances; anti-inflammatory effect: may be by inhibiting the synthesis of prostaglandins or other inflammatory substances; antipyretic effect: may be by acting on the hypothalamic temperature regulation center to cause peripheral vasodilation, sweating and increased heat dissipation; anti-rheumatic effect: in addition to antipyretic and analgesic, it mainly has anti-inflammatory effect; inhibitory effect on platelet aggregation: by inhibiting platelet prostaglandin cyclooxygenase, preventing the formation of thromboxane A2.

More

Analgesic effect: by inhibiting the synthesis of prostaglandins and other substances; anti-inflammatory effect: may be by inhibiting the synthesis of prostaglandins or other inflammatory substances; antipyretic effect: may be by acting on the hypothalamic temperature regulation center to cause peripheral vasodilation, sweating and increased heat dissipation; anti-rheumatic effect: in addition to antipyretic and analgesic, it mainly has anti-inflammatory effect; inhibitory effect on platelet aggregation: by inhibiting platelet prostaglandin cyclooxygenase, preventing the formation of thromboxane A2.

50-78-2 35
Diclofenac Sodium Enteric-Coated Tablets
The main ingredient of this product is diclofenac. Its chemical name is [o-(2,6-dichloroaniline)]phenylacetic acid.
Name Description Content CAS NO. Registered Holders
1-(2,6-Dichlorophenyl)-2-indolinone

Diclofenac is a non-steroidal anti-inflammatory analgesic derived from phenylacetic acid. Its mechanism of action is to inhibit the activity of cyclooxygenase, thereby blocking the conversion of arachidonic acid into prostaglandins. At the same time, it can also promote the combination of arachidonic acid with triglycerides (triacylglycerols), reduce the concentration of free arachidonic acid in cells, and indirectly inhibit the synthesis of leukotrienes. Diclofenac is a stronger non-steroidal anti-inflammatory drug, and its inhibitory effect on prostaglandin synthesis is stronger than that of aspirin and indomethacin.

More

Diclofenac is a non-steroidal anti-inflammatory analgesic derived from phenylacetic acid. Its mechanism of action is to inhibit the activity of cyclooxygenase, thereby blocking the conversion of arachidonic acid into prostaglandins. At the same time, it can also promote the combination of arachidonic acid with triglycerides (triacylglycerols), reduce the concentration of free arachidonic acid in cells, and indirectly inhibit the synthesis of leukotrienes. Diclofenac is a stronger non-steroidal anti-inflammatory drug, and its inhibitory effect on prostaglandin synthesis is stronger than that of aspirin and indomethacin.

15307-86-5 4
Piroxicam Tablets
The main ingredients of this product and their chemical names are: The main ingredient of this product is piroxicam, and its chemical name is 2-methyl-4-hydroxy-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide.
Name Description Content CAS NO. Registered Holders
Piroxicam

It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. This product exerts its pharmacological effects by inhibiting cyclooxygenase, reducing the synthesis of prostaglandins in local tissues, inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes.

More

It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. This product exerts its pharmacological effects by inhibiting cyclooxygenase, reducing the synthesis of prostaglandins in local tissues, inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes.

36322-90-4 33
Berberine Trimethoprim Capsules
This product is a compound preparation, and its components are: each tablet contains 100 mg of berberine hydrochloride and 50 mg of trimethoprim.
Name Description Content CAS NO. Registered Holders
Berberine hydrochloride

It has an inhibitory effect on a variety of Gram-positive and Gram-negative bacteria in vitro, and has a stronger inhibitory effect on hemolytic Streptococcus, Staphylococcus aureus, Vibrio cholerae, Neisseria meningitidis, Shigella, Salmonella typhi, Corynebacterium diphtheriae, etc. It also has a certain inhibitory effect on amoeba.

More

It has an inhibitory effect on a variety of Gram-positive and Gram-negative bacteria in vitro, and has a stronger inhibitory effect on hemolytic Streptococcus, Staphylococcus aureus, Vibrio cholerae, Neisseria meningitidis, Shigella, Salmonella typhi, Corynebacterium diphtheriae, etc. It also has a certain inhibitory effect on amoeba.

100mg 633-65-8 46
Trimethoprim

It mainly interferes with bacterial folate metabolism, selectively inhibits dihydrofolate reductase, and prevents nucleic acid synthesis.

More

It mainly interferes with bacterial folate metabolism, selectively inhibits dihydrofolate reductase, and prevents nucleic acid synthesis.

50mg 738-70-5 44
Oyster calcium carbonate tablets
The main component of this product is calcium compounds mainly composed of calcium carbonate and calcium hydroxide, which are obtained by calcining oyster shells at high temperature.
Name Description Content CAS NO. Registered Holders
Calcium compounds from oyster shells (mainly calcium carbonate and calcium hydroxide)

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.